7 recommendations to increase training consistency for patients self-injecting biologics
Biologic drugs are finding growing success in addressing chronic diseases — from diabetes and rheumatoid arthritis to multiple sclerosis and Crohn’s. A significant rise in self-injection therapies is contributing to… Read More »
Supporting Improved Patient Onboarding and Adherence With Training Solutions
With more biologics and drug delivery device options entering the market in recent years, pharma companies can decide whether it would be easier for patients to self-inject with an autoinjector… Read More »
Enhancing the Patient Experience for Self-Injection Systems Through Demonstration Devices
Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »
Response to News Release from 215 Biopharma KOLs
In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn… Read More »
Noble’s Self-Injection Trainers for Rheumatoid Arthritis Drugs
Last year, Medgadget heard from Noble International about its smart training devices that educate patients on safe and effective at-home use of prefilled syringes and autoinjectors. At the time, Joe Reynolds, Research Manager… Read More »
How Well Are Your Rheumatology Patients Self-Administering Their Medication?
A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options,… Read More »